INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Clinical trial NCT03539302 · COMPLETED

Trial details

NCT number: NCT03539302
Sponsor: InCarda Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Paroxysmal Atrial Fibrillation (PAF)

Start date: 2018-05-29
Primary completion: 2022-01-17
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.